DurgicalDurgical
EN
Open the app

Inhaled antimuscarinics !

Inhaled blockers of the muscarinic receptor that open the airways by cutting vagal tone. A mainstay of COPD; tiotropium is also added in severe asthma.

Updated 2026-11-01

What they are

Quaternary ammonium antagonists of muscarinic receptors given by inhalation. The short-acting agent (SAMA) is ipratropium; long-acting agents (LAMA: tiotropium, umeclidinium, aclidinium, glycopyrronium) are maintenance bronchodilators in COPD and reduce its exacerbations. They are often combined with a beta-2 agonist.

Mechanism of action

Vagal nerves release acetylcholine onto M3 receptors of airway smooth muscle and glands, which causes bronchoconstriction and mucus secretion. Blocking M3 removes this cholinergic tone; the effect is larger in COPD, where vagal tone is the main reversible part of the obstruction. Being quaternary, these drugs are poorly absorbed and barely cross the blood-brain barrier, so systemic effects are few.

Target: Muscarinic acetylcholine receptor M3 (CHRM3) of airway smooth muscle

Drugs in this class

Others in the class

  • Umeclidinium
  • Aclidinium
  • Glycopyrronium

Test yourself

Think of the answer, then tap the question to see it.

Why do inhaled antimuscarinics cause few central nervous system effects?

They are quaternary ammonium compounds: permanently charged, poorly absorbed and barely able to cross the blood-brain barrier.

Which two conditions call for caution with inhaled antimuscarinics?

Narrow-angle glaucoma and urinary retention (prostatic hyperplasia or bladder-neck obstruction).

Why are antimuscarinics especially useful in COPD?

Vagal cholinergic tone is the main reversible component of airway narrowing in COPD, and long-acting agents also cut exacerbations.

Add to my cards (3)

← All of pharmacology

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: DailyMed - TIOTROPIUM BROMIDE capsule (DailyMed (U.S. National Library of Medicine), 2025); DailyMed - IPRATROPIUM BROMIDE solution (DailyMed (U.S. National Library of Medicine), 2026); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 44 (McGraw Hill, 2023).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.